Pay in 4 interest-free payments of $15.00 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
TMPA was intraperitoneally (IP) dosed to mice at 50 mg/kg once per day
1616391-87-7
leading to bioenergetic catastrophe and tumour cell death
74(1):116-24
BMS-201038 - CAS# 182431-12-5 size:2mg solid TMPA was intraperitoneally (IP) dosedBMS 201038, CAS No. 182431 12 5, is a MTP inhibitor. Lomitapid is a novel agent for the treatment of homozygous familial hypercholesterolemia. Lomitapide is an orally active inhibitor of microsomal triglyceride transfer protein that is indicated as an adjunct to a low fat diet and other lipid lowering treatments, including LDL apheresis where available for the reduction of LDL C, total cholesterol, apolipoprotein B, and non high density lipoprotein
US$ 32.00
US$ 22.00
US$ 82.00
US$ 79.00